Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,061,566
-$85,080 QoQ
Shares Held
44,085
+8.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,295
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Palisade Asset Management, LLC holds $93,677,669 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
72,776 | $26,353,645 | |
| 2 | JNJ |
Johnson & Johnson
|
100,872 | $25,618,461 | |
| 3 | LLY |
ELI LILLY & Co
|
14,193 | $17,023,511 | |
| 4 | ABBV |
AbbVie Inc.
|
62,276 | $15,671,132 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,395 | $4,548,257 | |
| 6 | NVS |
Novartis AG
|
15,639 | $2,450,944 | |
| 7 | PFE |
Pfizer Inc
This page
|
44,085 | $1,061,566 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,490 | $950,153 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,061,566 | 44,085 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,146,646 | 40,835 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,044,828 | 41,961 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,102,417 | 43,266 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,061,372 | 43,786 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,215,965 | 47,986 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,334,803 | 50,313 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,453,800 | 50,235 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,369,341 | 48,940 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,357,946 | 48,935 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,359,895 | 47,235 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,702,616 | 51,330 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,828,681 | 49,855 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,021,844 | 49,555 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,496,156 | 48,715 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,113,170 | 48,290 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,558,584 | 48,800 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,457,004 | 47,460 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $2,589,933 | 43,860 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,970,288 | 45,810 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,765,332 | 45,080 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,579,120 | 43,586 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $2,427,877 | 65,957 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,383,002 | 64,932 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,123,278 | 64,932 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $2,025,537 | 62,057 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||